Marin Endocrine News
Looking Forward after 30 Years of Service
As the calendar turned the first pages of 2019, we at Marin Endocrine Care and Research began the 31st year of our clinical practice of Endocrinology and pharmaceutical Clinical Research! We are proud of our history of medical service in the Community these decades and grateful that we have been chosen by our colleagues and patients both to provide endocrinology consulting care as well as to participate in hundreds of the most cutting edge developments in clinical pharmaceutical drug trial research and device/technology development.
The past 30 years have brought growth and expansion of our experience, staff and space. We are excited to announce that our two new associates have become full colleagues in our practice and have assumed full roles as Principal and Sub Investigators in all our clinical research protocols. We are very proud to introduce Dr Mickie Cheng MD PhD and Dr Alex Uihlein MD who both chose to join our practice two years ago in part because of their research interests, training and backgrounds. Drs Cheng and Uihlein have impressive training and credentials and extensive experience in endocrinology, both clinical and research, and are looking forward to further developing the scope of our research and practice. Tina McCord, our office manager of over 25 years and our research staff including Jesse Cardozo, our clinical manager of over 10 years, and our experienced staff of clinical coordinators, will continue to move the capabilities of Marin Endocrine Care and Research forward as a cohesive team.
As of January 1st, Dr. Richard Bernstein retired but will remain a friend and colleague after a career of over 45 years in medical practice! He leaves MECR in good hands and we salute him for his early, innovative involvement in clinical research. He will be missed but the last two years were ones of deliberate coordination for the safe and smooth transition of study responsibilities to Drs Cheng, Uihlein and myself. In our new configuration we plan to continue to participate in diabetes related trials, cardiometabolic, and bone health studies and also plan to expand into other appropriate research areas within our endocrine specialty and in related specialties such as women’s and men’s health, pain management and others.
We invite you to review the Bios and CVs of each of us, visit our website, visit our practice and research offices. Please do not hesitate to call us with questions about ongoing and upcoming studies. We look forward to continuing our valued and rich relationships and initiating new exciting ones as well.